# Clinical Efficacy and Long-term Outcomes of ALLOgraft Versus Stented Biological Prosthesis for Primary TRIcuspid Valve Disease (ALLOTRI)

> **NCT06591000** · — · RECRUITING · sponsor: **Chelyabinsk Regional Clinical Hospital** · enrollment: 56 (estimated)

## Conditions studied

- Allograft
- Bioprosthesis
- Tricuspid Valve Disease

## Interventions

- **PROCEDURE:** tricuspid valve replacement

## Key facts

- **NCT ID:** NCT06591000
- **Lead sponsor:** Chelyabinsk Regional Clinical Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2016-01-14
- **Primary completion:** 2024-12-14
- **Final completion:** 2025-06-14
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06591000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06591000, "Clinical Efficacy and Long-term Outcomes of ALLOgraft Versus Stented Biological Prosthesis for Primary TRIcuspid Valve Disease (ALLOTRI)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06591000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*